(PRM) Perimeter Solutions - Overview
Stock: Fire Retardants, Firefighting Foam, Lubricant Additives, Phosphorus Pentasulfide
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 47.1% |
| Relative Tail Risk | -10.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.81 |
| Alpha | 108.38 |
| Character TTM | |
|---|---|
| Beta | 0.939 |
| Beta Downside | 0.985 |
| Drawdowns 3y | |
|---|---|
| Max DD | 67.63% |
| CAGR/Max DD | 0.65 |
Description: PRM Perimeter Solutions January 13, 2026
Perimeter Solutions, Inc. (NYSE: PRM) manufactures firefighting products-including fire-retardants and foams-and lubricant additives, operating from the United States, Germany, and other export markets. The firm is split into a Fire Safety segment that serves federal, state, provincial, municipal and commercial customers with fire-suppression equipment and services, and a Specialty Products segment that produces phosphorus-pentasulfide-based additives for pesticide, mining-chemical, and electric-battery applications. Founded in 1963, its headquarters are in Clayton, Missouri, with a primary fire-retardant plant in Sacramento, California.
Key operating metrics (FY 2023) show revenue of roughly $210 million, with the Fire Safety segment contributing about 65 % of sales and the Specialty Products segment the remaining 35 %. Gross margins hover near 38 % and the company reported a backlog of $45 million, indicating steady demand. Growth drivers include rising regulatory pressure on fire-safety compliance (e.g., NFPA 101 updates) and expanding demand for low-phosphorus lubricant additives in the battery-energy-storage sector, which is projected to grow at a CAGR of 12 % through 2030. Conversely, exposure to volatile commodity prices (phosphorus, sulfur) and potential tightening of environmental regulations on firefighting foams constitute material risks.
If you want a data-rich, side-by-side comparison of PRM’s valuation and peer metrics, ValueRay’s platform offers a quick, free snapshot worth checking out.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 78.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -1.10 > 1.0 |
| NWC/Revenue: 50.37% < 20% (prev 61.15%; Δ -10.78% < -1%) |
| CFO/TA 0.08 > 3% & CFO 222.9m > Net Income 78.0m |
| Net Debt (367.2m) to EBITDA (96.7m): 3.80 < 3 |
| Current Ratio: 2.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (146.8m) vs 12m ago 1.09% < -2% |
| Gross Margin: 55.86% > 18% (prev 0.55%; Δ 5530 % > 0.5%) |
| Asset Turnover: 24.92% > 50% (prev 21.69%; Δ 3.22% > 0%) |
| Interest Coverage Ratio: 0.69 > 6 (EBITDA TTM 96.7m / Interest Expense TTM 38.6m) |
Altman Z'' -0.39
| A: 0.12 (Total Current Assets 584.2m - Total Current Liabilities 263.6m) / Total Assets 2.65b |
| B: -0.25 (Retained Earnings -652.9m / Total Assets 2.65b) |
| C: 0.01 (EBIT TTM 26.6m / Avg Total Assets 2.55b) |
| D: -0.43 (Book Value of Equity -662.4m / Total Liabilities 1.53b) |
| Altman-Z'' Score: -0.39 = B |
Beneish M -3.06
| DSRI: 0.92 (Receivables 106.7m/97.6m, Revenue 636.3m/534.2m) |
| GMI: 0.99 (GM 55.86% / 55.39%) |
| AQI: 0.93 (AQ_t 0.73 / AQ_t-1 0.79) |
| SGI: 1.19 (Revenue 636.3m / 534.2m) |
| TATA: -0.05 (NI 78.0m - CFO 222.9m) / TA 2.65b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of PRM shares?
Over the past week, the price has changed by +1.25%, over one month by -3.35%, over three months by +11.01% and over the past year by +121.20%.
Is PRM a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PRM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33 | 23.1% |
| Analysts Target Price | 33 | 23.1% |
| ValueRay Target Price | 32.2 | 20.1% |
PRM Fundamental Data Overview January 31, 2026
P/E Forward = 18.8679
P/S = 6.0393
P/B = 3.5246
Revenue TTM = 636.3m USD
EBIT TTM = 26.6m USD
EBITDA TTM = 96.7m USD
Long Term Debt = 668.8m USD (from longTermDebt, last quarter)
Short Term Debt = 4.42m USD (from shortTermDebt, last quarter)
Debt = 707.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 367.2m USD (from netDebt column, last quarter)
Enterprise Value = 4.21b USD (3.84b + Debt 707.9m - CCE 340.6m)
Interest Coverage Ratio = 0.69 (Ebit TTM 26.6m / Interest Expense TTM 38.6m)
EV/FCF = 23.63x (Enterprise Value 4.21b / FCF TTM 178.2m)
FCF Yield = 4.23% (FCF TTM 178.2m / Enterprise Value 4.21b)
FCF Margin = 28.01% (FCF TTM 178.2m / Revenue TTM 636.3m)
Net Margin = 12.26% (Net Income TTM 78.0m / Revenue TTM 636.3m)
Gross Margin = 55.86% ((Revenue TTM 636.3m - Cost of Revenue TTM 280.9m) / Revenue TTM)
Gross Margin QoQ = 58.30% (prev 62.41%)
Tobins Q-Ratio = 1.59 (Enterprise Value 4.21b / Total Assets 2.65b)
Interest Expense / Debt = 1.39% (Interest Expense 9.87m / Debt 707.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 21.0m (EBIT 26.6m * (1 - 21.00%))
Current Ratio = 2.22 (Total Current Assets 584.2m / Total Current Liabilities 263.6m)
Debt / Equity = 0.64 (Debt 707.9m / totalStockholderEquity, last quarter 1.11b)
Debt / EBITDA = 3.80 (Net Debt 367.2m / EBITDA 96.7m)
Debt / FCF = 2.06 (Net Debt 367.2m / FCF TTM 178.2m)
Total Stockholder Equity = 1.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.06% (Net Income 78.0m / Total Assets 2.65b)
RoE = 6.69% (Net Income TTM 78.0m / Total Stockholder Equity 1.17b)
RoCE = 1.45% (EBIT 26.6m / Capital Employed (Equity 1.17b + L.T.Debt 668.8m))
RoIC = 1.15% (NOPAT 21.0m / Invested Capital 1.83b)
WACC = 8.09% (E(3.84b)/V(4.55b) * Re(9.38%) + D(707.9m)/V(4.55b) * Rd(1.39%) * (1-Tc(0.21)))
Discount Rate = 9.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.34%
[DCF Debug] Terminal Value 69.80% ; FCFF base≈184.1m ; Y1≈120.8m ; Y5≈55.1m
Fair Price DCF = 4.69 (EV 1.06b - Net Debt 367.2m = Equity 693.7m / Shares 147.9m; r=8.09% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 16.08 | EPS CAGR: 2.32% | SUE: 0.16 | # QB: 0
Revenue Correlation: 55.17 | Revenue CAGR: 67.22% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.01 | Chg30d=-0.015 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.26 | Chg30d=-0.147 | Revisions Net=-1 | Growth EPS=-7.7% | Growth Revenue=+16.3%